This compound is primarily utilized in the field of medicinal chemistry and pharmacology, particularly in the development of central nervous system (CNS) drugs. Its structure suggests potential activity as a ligand for nicotinic acetylcholine receptors, making it a candidate for research in treating neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Additionally, it may be explored for its potential in modulating cognitive functions and memory enhancement. The compound’s chiral nature allows for selective interaction with biological targets, which is crucial in designing drugs with fewer side effects. It is also used in preclinical studies to understand the pharmacological properties of pyrrolidine-containing compounds and their impact on receptor binding and signaling pathways.